| Property | Value |
|---|
|
?:abstract
|
-
Pregnancy is a prothrombotic condition characterized by a procoagulant imbalance that serves to protect women from bleeding but increases their risk for venous thromboembolism (VTE) [1]. Coronavirus disease 2019 (COVID-19) has not spared pregnant women with regards to VTE [2]. A coagulopathy that increases the risk of thrombosis has been reported in patients with severe COVID-19 infection [3]. At present, no data are available on the hemostatic status of pregnant women with COVID-19, and whether coagulation parameters are additionally influenced by COVID-19 remains unclear.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
-
International_journal_of_gynaecology_and_obstetrics:_the_official_organ_of_the_International_Federation_of_Gynaecology_and_Obstetrics
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Hemostasis in pregnant women with COVID-19.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}